Skip to main content
. Author manuscript; available in PMC: 2021 Oct 9.
Published in final edited form as: Hepatology. 2020 Oct 9;72(4):1298–1309. doi: 10.1002/hep.31146

Table 2.

Risk factors for all ECC cases, its subtypes pCCA and dCCA and respective controls

Risk factors All ECC vs Controls pCCA vs Controls dCCA vs Controls
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
Statin use 0.22 (0.16–0.29) <0.0001 0.3 (0.21–0.41) <0.0001 0.06 (0.03–0.14) <0.0001
BMI 0.97 (0.94–0.99) 0.004 0.95 (0.92–0.98) <0.001 1.01 (0.97–1.05) 0.77
DM 0.73 (0.56–0.94) 0.015 0.63 (0.46–0.87) 0.005 0.94 (0.61–1.44) 0.77
IBD 8.2 (4.17–16.15) <0.0001 5.19 (2.44–11.02) <0.001 6.16 (0.80–47.13) 0.080
Cirrhosis 2.91 (2.02–4.19) <0.0001 3.28 (2.18–4.94) <0.001 1.88 (0.78–4.55) 0.16
HCV 7.33 (2.94–18.31) <0.0001 15.84 (4.06–61.87) <0.001 1.51 (0.33–6.85) 0.59
Other liver disease 4.01 (2.33–6.92) <0.0001 4.06 (2.24–7.36) <0.001 4.01 (2.33–6.92) <0.001
Smoking, n (%) 1.00 (0.79–1.27) 0.99 0.9 (0.67–1.22) 0.49 1.25 (0.83–1.9) 0.29
Alcohol use, n (%) 0.36 (0.28–0.47) <0.0001 0.34 (0.25–0.48) <0.0001 0.39 (0.25–0.6) <0.0001